July 11, 2017 / 8:14 PM / 4 months ago

BRIEF-Merus Q1 loss per share EUR 1.15

July 11 (Reuters) - Merus Nv:

* Merus announces first quarter 2017 financial results and mid-year operating results

* Q1 loss per share EUR 1.15

* Q1 revenue EUR 2.3 million versus EUR 800,000

* Q1 revenue view EUR 42.8 million -- Thomson Reuters I/B/E/S

* Q1 earnings per share view EUR 1.55 -- Thomson Reuters I/B/E/S

* Merus nv says by end of 2017, Merus expects to file a CTA for a first-in-human clinical trial of mcla-158 in patients with colorectal cancer Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below